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a b s t r a c t
The vertebrate inner ear is a morphologically complex sensory organ comprised of two compartments,
the dorsal vestibular apparatus and the ventral cochlear duct, required for motion and sound detection,
respectively. Fgf10, in addition to Fgf3, is necessary for the earliest stage of otic placode induction, but
continued expression of Fgf10 in the developing otic epithelium, including the prosensory domain and
later in Kolliker's organ, suggests additional roles for this gene during morphogenesis of the labyrinth.
While loss of Fgf10 was implicated previously in semicircular canal agenesis, we show that Fgf10 /þ
embryos also exhibit a reduction or absence of the posterior semicircular canal, revealing a dosage-
sensitive requirement for FGF10 in vestibular development. In addition, we show that Fgf10 / embryos
have previously unappreciated defects of cochlear morphogenesis, including a somewhat shortened
duct, and, surprisingly, a substantially narrower duct. The mutant cochlear epithelium lacks Reissner's
membrane and a large portion of the outer sulcus–two non-contiguous, non-sensory domains. Marker
gene analyses revealed effects on Reissner's membrane as early as E12.5-E13.5 and on the outer sulcus by
E15.5, stages when Fgf10 is expressed in close proximity to Fgfr2b, but these effects were not
accompanied by changes in epithelial cell proliferation or death. These data indicate a dual role for
Fgf10 in cochlear development: to regulate outgrowth of the duct and subsequently as a bidirectional
signal that sequentially speciﬁes Reissner's membrane and outer sulcus non-sensory domains. These
ﬁndings may help to explain the hearing loss sometimes observed in LADD syndrome subjects with
FGF10 mutations.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The mammalian inner ear is a morphologically complex sen-
sory organ with two functionally distinct compartments, the
ventral auditory and dorsal vestibular divisions, which are respon-
sible for the perception of sound and movement, respectively. The
auditory compartment, the cochlea, derives from a ventral out-
growth of the otic vesicle epithelium, which undergoes progres-
sive extension and, in mammals, coils as it matures. Vestibular
structures derive from dorsal and lateral evaginations of the otic
epithelium and are sculpted into the three semicircular canals
used to detect angular acceleration, as well as two central pouches,
the utricle and saccule, used to detect linear acceleration. The
inner ear epithelium also has a dorsally projecting non-sensory
appendage, the endolymphatic duct and sac, which maintains the
unique ionic composition of the endolymph ﬂuid in the inner ear
lumen and is essential for normal sensory functions (Groves and
Fekete, 2012; Wu and Kelley, 2012).
Gross morphogenesis of the inner ear epithelium is largely com-
plete by E15.5 in the mouse (Morsli et al., 1998), at which time the
cochlea has achieved 1.75 turns and remodeling of dorsal orthogonal
epithelial pouches has resulted in formation of the three patent
semicircular canals (see Fig. 1A). Differentiation of the epithelium into
distinct sensory and non-sensory domains with their characteristic cell
types occurs concomitantly with gross morphogenesis and is not
complete until well after birth in mouse. Although many human
sensorineural deafness and balance disorders are caused by genetic
or environmental insults that affect the function of particular inner ear
cell types and are not detectable radiologically, almost 40% of inner ear
dysfunction may be accompanied by congenital malformation of the
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epithelium (Mafong et al., 2002; Wu et al., 2005) and the presence of
malformations impacts treatment plans. Therefore, to advance both
treatment and ultimately prevention, it is essential to elucidate the
functions of signals controlling otic morphogenesis.
Genetic analyses show that FGF signaling is particularly impor-
tant for inner ear morphogenesis. Multiple FGFs functioning from
nearby tissues induce formation of the otic placode in posterior
head ectoderm (Alvarez et al., 2003; Ladher et al., 2005; Wright
and Mansour, 2003; Zelarayan et al., 2007). The otic placode then
invaginates and closes, forming the spherical otic vesicle. Several
FGFs, whether signaling from the nearby hindbrain (FGF3) or from
within the otic epithelium itself (FGF3, FGF9 and FGF10) are
required for subsequent morphogenesis of the dorsal otic vesicle.
Mice that lack Fgf3 function fail with variable penetrance and
Fig. 1. Vestibular morphogenesis is affected in both Fgf10 heterozygous and Fgf10 homozygous null mutants, whereas cochlear development is affected only in homozygotes.
(A–E, G–K, M–Q, S–X) Inner ear epithelia were ﬁlled with paint at the stages indicated to the left of each row. Genotypes are indicated at the top of each column. The
phenotypic class designations for E13.5–E15.5 samples as described in the main text (C0–C4) are summarized in panel Y and indicated in the upper right portion of each
panel. The percentage of each E13.5–E15.5 genotype falling into each phenotypic class is shown (F, L, R). Abbreviations: aa, anterior ampula; ascc, anterior semicircular canal;
cd, cochlear duct; la, lateral ampula; lscc, lateral semicircular canal; pa, posterior ampula; pscc, posterior semicircular canal; vcp, vertical canal plate.
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expressivity to form an endolymphatic duct and the affected otic
vesicles develop variably, with impacts on both vestibular and
cochlear morphogenesis and function (Hatch et al., 2007; Mansour
et al., 1993). The relative contributions of hindbrain and otic
epithelial Fgf3 to these phenotypes have not been determined.
Mice lacking Fgf9, which is expressed in non-sensory domains of
both the vestibular and cochlear epithelia, have severe abnormalities of
vestibular morphogenesis. Semicircular canals are absent or rudimen-
tary and these phenotypes are thought to arise from disrupted
communication between the otic epithelium and the surrounding
mesenchyme. The cochlear abnormalities of Fgf9 mutants are subtle.
The cochlear epithelium appears relatively normal, but mesothelial cells
adjacent to the epithelial component of Reissner's membrane, which is
normally a site of Fgf9 expression, fail to attach to the membrane and
the adjacent scala vestibuli (a channel cleared of mesenchyme and ﬁlled
with perilymph) is enlarged. This is consistent with a disruption of
epithelial/mesenchymal communication (Pirvola et al., 2004).
Finally, mice lacking Fgf10, which is expressed in both vestib-
ular and cochlear prosensory epithelial tissue as well as in the
developing otic ganglion, show complete agenesis of the posterior
sensory and non-sensory vestibular tissue (crista and posterior
semicircular canal, respectively), and have milder deformations of
the anterior and lateral cristae and their associated semicircular
canals. The otic ganglion forms normally, but innervation of the
vestibular system is disrupted, presumably due to the absence of
targets (Ohuchi et al., 2005; Pauley et al., 2003). In contrast, no
speciﬁc abnormalities of cochlear histogenesis or morphogenesis
were described, although Pauley et al. (2003) noted a slight
shortening of the cochlear duct. The individual contributions of
otic ganglion vs. epithelial sources of Fgf10 are unknown.
As a prelude to studies dissecting the individual and combinatorial
requirements for epithelial Fgf3 and Fgf10 in mouse otic morphogen-
esis, we observed that global Fgf10 heterozygous inner ears also
presented with vestibular defects (a small or absent posterior semi-
circular canal). Furthermore, the Fgf10 homozygous null mutant
cochlear duct was noticeably shorter and, most surprisingly, narrower
than that of heterozygous or wild type littermates. Histologic and
marker analyses revealed that while the cochlear sensory domain and
two non-sensory domains, Kolliker's organ (the inner sulcus) and the
stria vascularis, appeared to develop normally, epithelial tissue in two
other non-contiguous non-sensory domains was deleted; namely, all
of Reissner's membrane and a substantial portion of the outer sulcus.
Analysis of molecular markers during development showed that the
Reissner's membrane defect preceded the outer sulcus defect, and that
both could be correlated to loss of signaling from FGF10 to its major
receptor, FGFR2b, at times when the ligand and receptor were in close
proximity. However, we did not detect differences between controls
andmutants with respect to proliferation or cell death. Taken together,
these data demonstrate a previously unappreciated role for cochlear
FGF10 as a bi-directional signal that promotes sequential speciﬁcation
of non-contiguous non-sensory domains of the cochlear epithelium.
This is the ﬁrst report of such a signal and our ﬁndings have
implications for understanding the hearing loss of LADD syndrome
individuals bearing mutations in FGF10.
Materials and methods
These studies complied with protocols approved by the Uni-
versity of Utah Institutional Animal Care and Use Committee.
Generation of Fgf10 null embryos
Generation and PCR genotyping of the Fgf10 null allele (Fgf10 ,
also known as Fgf10Δ2 and formally designated Fgf10tm1.1Sms;
MGI:3526181) were described previously (Urness et al., 2010).
Fgf10 /þ mice were maintained on a mixed genetic background
comprised of C57Bl/6 and various 129 substrains. Fgf10 /þ adults
were intercrossed and noon of the day on which a mating plug
was observed was designated as E0.5.
Paintﬁlling of embryonic inner ears
E11.5–E15.5 embryos were ﬁxed in Bodian's solution, dehydrated
in ethanol, cleared with methyl salicylate and the inner ear lumens
ﬁlled with white latex paint as described (Kiernan, 2006; Morsli et
al., 1998). Filled ears were roughly dissected and photographed
under darkﬁeld illumination using a QImaging Micropublisher
digital camera mounted on a Zeiss Discovery V.12 microscope.
RNA in situ hybridization to parafﬁn sections
Heads of E12.5-E18.5 intercross embryos were ﬁxed in modiﬁed
Carnoy's solution, embedded in parafﬁn (Paraplast X-tra) and 10 mm
sections were dewaxed, blocked and hybridized with digoxigenin-
labeled anti-sense RNA probes, which were detected with alkaline-
phosphatase conjugated anti-digoxigenin antibodies as described
(Urness et al., 2008). Probes for Fgf10,Myo6, Lgr5, Fgfr1, Spry2, Spry1,
Bmp4, Fgfr2, Fgf9, and Lnfg were generated by transcription of
cDNA-containing plasmids. A list of the template plasmids and
acknowledgments is found in Supplementary Table 1. The rest of
the RNA probes were generated by transcription of a PCR-ampliﬁed,
gene-speciﬁc 30 UTR fragment containing a T7 promoter. The primer
sequences can be found in Supplementary Table 2.
Immunoﬂuorescence analysis of inner ear frozen sections
Whole E18.5 heads were bisected in the sagittal or transverse
plane and ﬁxed for 2 h at room temperature in 4% paraformalde-
hyde prepared in phosphate buffered saline (PBS). Heads were
cryoprotected and embedded in sucrose/gelatin as described
(Hurley et al., 2003) with the following modiﬁcations: 5% sucrose
inﬁltration overnight at 4 1C, 15% sucrose inﬁltration overnight at
4 1C, 15% sucrose/7.5% gelatin (Bloom 300, Sigma G2500) inﬁltration
at 37 1C overnight. Samples were cryosectioned at 10 μm thickness
(6 mm for proliferation studies) in the sagittal plane, collected on
SuperFrost Plus slides and stored at 20 1C. Primary antibodies
were diluted into PBS/5% normal serum of the secondary antibody
species/0.2% Triton X-100 and applied at the following dilutions:
mouse anti-p27[Kip1] (BD Biosciences #610241), 1:300; rat anti-
CD44 (BD Biosciences #550538), 1:800; rabbit anti-MYO7A (Proteus
Biosciences #25-6790), 1:800; goat anti-SOX2 (Santa Cruz Biotech-
nology #sc-17320), 1:200; rabbit anti-S100 (Millipore #07-476),
1:1000; rabbit anti-cleaved Caspase-3 (Cell Signaling 9661), 1:100;
rabbit anti-phospho-Histone H3 (Millipore 06-570), 1:400. Permea-
bilization was enhanced by one hr incubation in PBS/1% deoxycho-
late/0.2% Triton X-100 at room temperature. Secondary antibodies
were all from Invitrogen and diluted 1:350 into PBST/5% normal
serum (Alexa Fluors 594 goat anti-rat (A11007); Alexa Fluors 488
goat anti-rabbit (A11034); and Alexa Fluors 594 donkey anti-goat
(A11058) Alexa Fluors 488 donkey anti-goat (A11055); Alexa
Fluors 488 donkey anti-rabbit (A21206). DAPI was included in
the mounting medium (Vectashield, Vector Labs) and ﬂuorescent
signal channels were overlaid using Photoshop CS4.
Analysis of cochlear duct proliferation
Pregnant dams (E13.5) were injected once with BrdU solution
(50 mg/g body weight, Invitrogen 00-0103), harvested 1 h later and
ﬁxed overnight in 4% PFA. Heads were inﬁltrated with sucrose/
gelatin and 6 mm cryosections prepared as described above. DNA
was denatured by incubating the slides in 1 N HCl at 481 for 30
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min, followed by neutralization in PBS. BrdU was detected as
described above using a mouse monoclonal antibody, MoBu-1
(Invitrogen B35128) at 1:100 and Alexa Fluors 594 goat anti-
mouse (Invitrogen A11032). For analysis at E11.5, cryosections
were prepared and phospho-Histone H3 was detected as described
above. To differentiate between sensory and non-sensory duct
domains, we co-stained the sections to detect SOX2 also as
described above. E11.5 data came from 8 sections in each of
6 controls and 6 Fgf10 null mutants. E13.5 data came from
5 sections in each of 4 controls and 4 Fgf10 null mutants. Student's
t-test (unpaired, two-tailed; Prism 6.0) was used to compare the
mean number of BrdU or phospho-Histone H3-positive cells per
unit area in control and Fgf10 / samples. SOX2-positive and
SOX2-negative domains were considered separately.
Cochlear duct cross-sectional area analysis
For the E18.5 measurements of the three scalae, we photo-
graphed the cochlea in H&E-stained sagittal sections of the head.
Three sections spaced at 50 mm intervals near the center of each of
3 control and 3 Fgf10 / inner ears were analyzed. The AxioVison
measurement module (Zeiss) was used to measure the area of
each the three scalae in the basal cross section and the three
measurements for each sample were averaged. The average area of
each scala from the 3 control and 3 mutant samples were
compared using multiple t tests. Statistical signiﬁcance was
determined using the Holm–Sidak method (Prism 6.0 software).
For E12.5 and E13.5 scala media area measurements, three con-
tiguous sections were photographed from the cochlear base of
3 control and 3 Fgf10 / inner ears sectioned coronally. For E15.5
scala media area measurements, three contiguous images were
captured representing the most basal turn. Area measurements
were captured and analyzed as described above.
Results
Fgf10 is required for both vestibular and cochlear morphogenesis
It is well known that Fgf10 is required for morphogenesis of the
vestibular system. Speciﬁcally, Fgf10 null inner ears lack posterior
sensory and non-sensory tissue (the cristae and semicircular
canals, respectively), and have variable defects of anterior and
lateral semicircular canal morphogenesis, or appear to have un-
fused vertical and lateral canal pouches (Ohuchi et al., 2005;
Pauley et al., 2003). The status of the cochlear duct is less clear,
with one report of a somewhat shortened, but otherwise normal
cochlea (Pauley et al., 2003) and another report of a cochlea of
normal length (Ohuchi et al., 2005). To enable morphologic
assessment of multiple inner ears of each Fgf10 genotype we
intercrossed Fgf10 /þ animals, collected embryos at E15.5 when
morphogenesis is virtually complete (Morsli et al., 1998), and
paint-ﬁlled the inner ear epithelia. Visual inspection revealed ﬁve
morphologic classes (Fig. 1A–E, Y). All 16 wild type ears were
normal (Class 0, Fig. 1A). In contrast, only ﬁve of 48 heterozygous
inner ears were normal, whereas 32 showed a reduced posterior
semicircular canal (pscc; Class 1, Fig. 1B) and 11 virtually lacked the
pscc, though the posterior ampulla (pa, housing the posterior
crista) was present (Class 2, Fig. 1C). Homozygotes were even more
severely affected and fell into two classes. As previously observed
by other groups (Ohuchi et al., 2005; Pauley et al., 2003), all 24
Fgf10 / inner ears lacked the posterior ampulla and canal. We
also observed small and variable reductions in the lateral and
anterior semicircular canals, but these were not quantiﬁed.
Furthermore, all Fgf10/ inner ears had a variably shortened
cochlear duct (cd; 0.75–1.5 turns; Fig. 1D and E). In 15 of 24
Fgf10/ inner ears, the process of canal pouch fusion to make an
anterior semicircular canal was complete (Class 3, Fig. 1D),
whereas in the other 9 inner ears the remaining portion of the
vertical canal pouch (vcp) failed to fuse and clear (Class 4, Fig. 1E).
These results revealed dosage sensitive requirements for Fgf10 in
vestibular morphogenesis and an unexpected requirement in
cochlear morphogenesis (Fig. 1F).
To determine when the abnormalities seen in Fgf10 /þ and
Fgf10 / inner ears were ﬁrst apparent, we paint-ﬁlled embryonic
inner ears from Fgf10 /þ intercrosses at progressively earlier
stages of development. All ﬁve previously deﬁned classes
(Fig. 1Y) were apparent at both E14.5 (Fig. 1G–K) and E13.5
(Fig. 1M–Q) in proportions roughly similar to those seen at E15.5
(Fig. 1F, L and R). Therefore the vestibular and cochlear abnorm-
alities noted at E15.5 must have initiated before E13.5.
At E12.5, only three morphologic classes were clearly distin-
guishable and these correlated with genotype. At this stage there
was variability across all genotypes with respect to the extent of
canal pouch fusion plate clearing and this correlated with overall
embryo size and developmental stage; i.e. younger embryos had
uncleared fusion plates and older ones had cleared, so this
parameter was not considered. All 18 E12.5 wild type inner ears
were normal (Fig. 1S). Virtually all (35/36) heterozygotes showed a
reduction in the posterior semicircular canal, but we could not
clearly distinguish reduction from complete absence (Fig. 1T), and
all 13 homozygotes had a reduced/absent posterior canal and a
shortened cochlear duct (Fig. 1U). Therefore, Fgf10 is required for
normal vestibular and cochlear development before E12.5.
At E11.5, a stage at which no embryonic inner ears showed
canal pouch fusion plate clearing, only two morphologic classes
were evident. All 26 wild type and all 38 heterozygous embryos
had a normal morphology (Fig. 1V and W) and all 14 homozygotes
appeared narrower than normal along the anterior-posterior axis
and had a cochlear duct that had not initiated coiling (Fig. 1X).
Therefore, Fgf10 heterozygosity has its ﬁrst effect on vestibular
morphogenesis between E11.5 and E12.5, whereas the complete
absence of Fgf10 affects both vestibular and cochlear morphogen-
esis as early as E11.5. We did not attempt to paint-ﬁll E10.5
intercross inner ears, but histologic studies of a limited number
of samples did not reveal obvious differences between genotypes
(Suppl. Fig. 1). Since the Fgf10 null vestibular phenotype has been
well documented (Ohuchi et al., 2005; Pauley et al., 2003), but the
cochlear phenotype is relatively unexplored, we focused subse-
quent studies on the cochlea.
Fgf10 is required for development of two discrete regions of non-
sensory cochlear epithelial tissue
To determine whether the abnormal cochlear morphogenesis
observed in Fgf10 / inner ears was accompanied by any cellular
changes, we compared hematoxylin and eosin-stained histologic
sections of Fgf10 / cochlear ducts with those from Fgf10 /þ and
Fgf10þ /þ embryos. As anticipated from the observations of E15.5
paint-ﬁlled inner ears, sagittal sections taken through E18.5
Fgf10þ /þ and Fgf10/þ cochleae revealed a normal auditory
structure with four cross sections of the cochlear duct visible
(Fig. 2A and B), whereas Fgf10 / cochleae were shorter and less
extensively coiled, with only three cross sections of the cochlear
duct evident (Fig. 2C). We were surprised to ﬁnd that the Fgf10 null
cochlear duct (scala media, m) was not simply shorter, but also had
a signiﬁcantly reduced cross-sectional area. In the basal turn, the
cross sectional area of the mutant scala media averaged only 17.6%
of the corresponding wild type or heterozygous area (n¼3;
Po0.0009), whereas there was no signiﬁcant difference between
mutants and controls with respect to the cross sectional area of
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the basal scala tympani (t) or scala vestibuli (v) (Fig. 2D). Further-
more, compared to wild type and heterozygous cochlear ducts
(Fig. 2A0 and B0), Fgf10 / cochlear ducts appeared to lack
Reissner's membrane (Rm) and much of the outer sulcus (os)
(Fig. 2C0). The Fgf10 / samples appeared to have a normally
developed sensory organ of Corti (oC), as well as the non-sensory
Kolliker's organ/inner sulcus (Ko), stria vascularis (sv) and spiral
ganglion (sg) (Fig. 2A0–C0). Higher magniﬁcation views conﬁrmed
the normal morphologic appearance and number of inner (þ) and
outer (n) hair cells, as well as a full complement of the organ of
Corti supporting cells in all samples (Fig. 2A″–C″).
Molecular markers of Reissner's membrane and the outer sulcus are
missing or reduced in Fgf10 null cochleae
To better characterize the differences between Fgf10 genotypes at
E18.5 we used RNA in situ hybridization or immunostaining of
cochlear duct cross sections to detect expression of genes and
proteins characteristic of the various cell types. Among these markers
was Fgf10 itself, as the transcript produced by the mutant allele (a
deletion of exon 2 that causes a frameshift) is stable (Urness et al.,
2011). Consistent with the histologic study, no differences between
genotypes were detected using markers of Kolliker's organ (Fgf10,
Jag1 and Tecta; Fig. 3A–F, O–P), hair cells (Myo6; Fig. 3J–L), organ of
Corti supporting cells (Jag1, Lfng, p27Kip and Tecta; Fig. 3D–I, M–P),
and the intermediate and basal cell layers of the stria vascularis (Trp2
and Cldn11, respectively; Fig. 3Q–T). Because we observed no
differences in cochlear histology or marker gene expression between
Fgf10þ /þ and Fgf10þ / samples, we used these genotypes inter-
changeably as controls in subsequent analyses.
In contrast to the results with Kolliker's organ, organ of Corti and stria
vascularis markers, markers of Reissner's membrane normally expressed
in either the epithelial (e) or mesenchymal/mesothelial (m) layers (Fgf9,
Cdh23 and Lmx1a, and Aldh1a2 (previously, Raldh2), respectively) were
absent from Fgf10 null cochleae (Fig. 4A–H). In addition, markers of the
outer sulcus (Lmx1a, Bmp4, Fgfr2, Slc26a4 and Lgr5) showed a reduced
Fig. 2. Fgf10 null cochlear ducts lack non-sensory domains and have a reduced cross-sectional area. Hematoxylin and eosin-stained E18.5 cochlear duct cross sections at
three magniﬁcations. Boxes in A–C indicate the region magniﬁed in A0–C0 . Dashed boxes in A0–C0; indicate the region magniﬁed in A″–C″. C″ Morphologic structures
remaining in Fgf10 mutants are indicated with lines. Genotypes are indicated to the left of each row. D. Graphical comparison of the cross sectional area of basal scalae (n¼3
controls and 3 mutants). Abbreviations: Ko, Kolliker's organ; m, scala media (cochlear duct), oC, organ of Corti; os, outer sulcus; Rm, Reissner's membrane; sg, spiral
(cochlear) ganglion; sv, stria vascularis; t, scala tympani; v, scala vestibuli. Asterisks indicate outer hair cells, plus symbols indicate inner hair cells. Scale bars in A, A0 , A″ apply
to all panels in the same column.
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domain in these mutants (Fig. 4E, F and I–P). However, Lmx1a and
Aldh1a2 expression in the stria vascularis was preserved (Fig. 4E–H)
similarly to Trp2 and Cldn11 at E18.5 (Fig. 3Q–T), further suggesting that
this tissue was unaffected by the absence of FGF10. Also, Cdh23
expression in Kolliker's organ and hair cells (Fig. 4C and D), and Lgr5
expression in Kolliker's organ (Fig. 4O and P) were retained in Fgf10 null
cochleae, conﬁrming that these cells developed normally.
To further delineate the status of the Fgf10 null outer sulcus in
relation to the organ of Corti, we used combinations of antibodies.
MYO7A antibodies label hair cell soma and SOX2 antibodies label
nuclei in the lateral half of Kolliker's organ and all organ of Corti
supporting cells laterally, including Hensen's cells (Hume et al., 2007).
Consistent with all previous markers, these two markers revealed no
differences between Fgf10 genotypes (Fig. 4Q and R). CD44 antibodies
label cell surfaces in lateral Kolliker's organ, the outer pillar cell,
Claudius cells in the outer sulcus, Reissner's membrane and the stria
vascularis (Hertzano et al., 2010), whereas S100A1 antibodies label the
soma of the inner hair cell and all supporting cells except pillar cells
(Sage et al., 2005) and p75NTR antibodies label the inner pillar cells
(Mansour et al., 2013; Mueller et al., 2002). There were no differences
between genotypes with respect to S100A1 or p75NTR staining (Fig. 4S–
V, green), again showing that Fgf10 is not uniquely required for organ of
Corti supporting cell development. However, CD44 staining differed
markedly between genotypes. In Fgf10 null mutants, the Reissner's
membrane domain was absent, as was the lateral domain of the outer
sulcus, with only a few of the most medial Claudius cells remaining
(Fig. 4S–T and S0–T0 red). In contrast, outer pillar cell and stria vascularis
staining were preserved. Taken together, the histologic and marker
analyses performed at E18.5 show that Fgf10 null cochleae are missing
two non-contiguous, non-sensory regions of the epithelium, namely,
Reissner's membrane and most of the outer sulcus.
The requirement for Fgf10 in Reissner's membrane development
precedes that in outer sulcus development
To determine the ontogeny of the cellular defects found in E18.5
Fgf10 null cochleae and their relation to FGF signaling disruptions, we
examined the expression of genes for relevant cell type-speciﬁc
markers, as well as FGF signaling components and signaling indica-
tors at progressively younger stages. At E15.5, markers of the
presumptive Reissner's membrane, Cdh23 and Fgf9 (Pirvola et al.,
2004; Wilson et al., 2001),were absent in Fgf10 / samples (Fig. 5A–
D). Aldh1a2 is a marker of both the presumptive Reissner's mem-
brane region and the stria vascularis (Burton et al., 2004; Romand et
al., 2001, 2004), and only the former domain was missing from Fgf10
mutants (Fig. 5E and F). The outer sulcus markers, Bmp4 and Lmx1a
(Koo et al., 2009; Morsli et al., 1998) were present in mutants, but
had a reduced domain (Fig. 5G–J). At this stage and as noted by
Fig. 3. Markers of Kolliker's organ, supporting cells, hair cells and the stria vascularis are unchanged in E18.5 Fgf10 null mutants. In situ hybridization (A–L, O–T) or
immunostaining analysis (M, N) of cochlear cross sections. Genotypes are indicated to the left of each row and probes are indicated at the upper right of the top panel in each
series. Abbreviations: hc, hair cells; Ko, Kolliker's organ; sc, supporting cells; sv, stria vascularis. Scale bar in A applies to all panels.
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others (Pauley et al., 2003), Fgf10 transcripts were expressed in the
prosensory domain of the cochlear epithelium and in the spiral
ganglion. As expected, the stable transcripts produced from the Fgf10
exon 2 deletion allele had a similar distribution in the mutants
(Fig. 5K and L). Fgf3, which is often redundant with Fgf10, is
expressed just laterally of Fgf10 at the edge of the prosensory and
outer sulcus domains, but we found no changes in its expression in
Fgf10 mutants (Fig. S2A and B), suggesting that this region is intact.
FGF10 and FGF3 signal mainly through FGFR2b, which is the
primary FGFR2 isoform expressed in otic epithelium (Pirvola et al.,
2000). Therefore, we used a pan probe that detects all Fgfr2
transcripts, as a proxy for an Fgfr2b-speciﬁc probe. As expected
(Hayashi et al., 2010; Pirvola et al., 2000), this probe labeled the
entire non-sensory domain of the control otic epithelium, includ-
ing the prospective Reissner's membrane, stria vascularis and
outer sulcus (Fig. 5M). The Fgfr2 domain was reduced in Fgf10
mutants and was still conﬁned to the thin, non-sensory region
(Fig. 5N). FGF10 can also signal through FGFR1b, which is co-
expressed with FGFR1c in the otic epithelium (Mansour et al.,
2013; Pirvola et al., 2002), and as expected (Hayashi et al., 2010;
Pirvola et al., 2002), a pan probe for all Fgfr1 transcripts detected
broad expression throughout the cochlear epithelium, with a focus
just medial to the outer sulcus. This domain was still present in
Fgf10 null mutants (Fig. 5O and P).
Spry2 is a transcriptional target of FGF signaling through the
RAS/MAPK pathway (Minowada et al., 1999) and was detected as
Fig. 4. Markers of Reissner's membrane are absent and outer sulcus markers show a reduced domain in E18.5 Fgf10 null mutant cochleae. In situ hybridization (A–P) and
immunostaining (Q–V) analyses of basal cochlear duct cross sections. Genotypes are indicated to the left of each row and probes are indicated to the upper right of each pair
of panels. Insets in A, C, E, G showmagniﬁcations of Reissner's membrane. S0–T0 provide enlargements of S–T, with the arrow in T' indicating the remnant Claudius cells in the
mutant os. Abbreviations: Rm(e), Reissner's membrane-epithelial layer; Rm(m), Reissner's membrane-mesenchymal/mesothelial domain; os, outer sulcus. See Figs. 2 or 3
legend for others. Scale bar in A applies to all panels except S0–T0 . Scale bar in S0 applies to T0 .
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expected in a domain spanning the lateral prosensory and medial
outer sulcus region (Shim et al., 2005) and also weakly in the
prospective Reissner's membrane. The Reissner's membrane
domain was absent from mutants and the outer sulcus domain
was reduced (Fig. 5Q and R). Several other transcriptional targets
of FGF signaling (Erm, Pea3, Spry1 and Dusp6) were found in the
epithelium or surrounding mesenchyme, but none of these was
affected in the Fgf10 mutants (Suppl. Fig. S2C–V). Together, these
Fig. 5. Presumptive Reissner's membrane markers are absent and presumptive outer sulcus markers show a reduced domain in E15.5 Fgf10 null mutant cochleae. In situ
hybridization analyses of basal cochlear duct cross sections are shown. Genotypes are indicated to the left of each row and probes are indicated to the upper right of each pair
of panels. Dashed and solid lines indicate expression that is altered or unchanged, respectively, in mutants. Abbreviations: Ko, presumptive Kolliker's organ; os, presumptive
outer sulcus; ps, presumptive prosensory domain; Rm, presumptive Reissner's membrane; sg, spiral ganglion; sv, stria vascularis. Scale bar in A applies to all panels.
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results suggest that the blocks to Reissner's membrane and outer
sulcus development in Fgf10 mutants occurred earlier than E15.5.
Examination of a subset of the Reissner's membrane and outer
sulcus markers in sections taken through the base of the cochlear
duct at even earlier stages (E13.5 and E12.5) revealed stage-
speciﬁc differences. As previously observed (Pirvola et al., 2004),
the prospective Reissner's membrane marker, Fgf9, had a broad
expression domain encompassing most of the thin, non-sensory
cochlear epithelium in E12.5 and E13.5 controls (Fig. 6Aa nd K).
This domain was substantially reduced, but not completely elimi-
nated in stage-matched Fgf10 mutants (Fig. 6B and L). In contrast,
the prospective outer sulcus marker, Bmp4, had the same expres-
sion domain in controls and mutants at both stages (Fig. 6C, D, M
and N). At these stages and as previously noted by Pirvola et al.
(2000), Fgf10 was expressed in the control prosensory regions
(Fig. 6E and O) in a pattern almost exactly complementary to that
of Fgfr2 in the non-sensory tissue (Fig. 6G and Q). As expected, the
Fgf10 expression domain (reﬂecting perdurant exon 2 deletion
transcripts) was unchanged in Fgf10 mutants (Fig. 6F and P), but at
E12.5, the Fgfr2 domain in the roof of the mutant duct was reduced
(Fig. 6H) relative to the control (Fig. 6G). No further change in Fgfr2
expression was observed at E13.5 (Fig. 6Q and R). The FGF
signaling indicator, Spry1, did not overlap with Fgfr2, so presum-
ably reveals signaling through FGFR1, which is widely expressed at
these stages (Hayashi et al., 2010; Pirvola et al., 2002). The lateral
extent of Spry1 expression was signiﬁcantly reduced in Fgf10
mutants at both E13.5 (Fig. 6I and J) and E12.5 (Fig. 6S and T).
Spry2, which marks the lateral prosensory and medial outer sulcus
domains, was unchanged at this stage (Fig. S2U and V). Finally,
Fgf9, Fgfr2 and Spry1 were unaffected at E11.5 (data not shown).
Collectively, these data suggest that the speciﬁcation of Reissner's
membrane occurs relatively early in cochlear development, at or
before E12.5, while medial outer sulcus speciﬁcation follows
between E13.5 and E15.5.
To determine when the non-sensory tissue deletions affected
the overall cochlear duct area, we compared control and mutant
cochlear ducts at E12.5, E13.5 and E15.5. Although the mutant
means were always less than control means, the difference did not
reach signiﬁcance until E15.5 (Fig. 6U).
Proliferation and death of cochlear epithelial cells are
unaffected in Fgf10 null mutants
To determine whether Fgf10 is necessary for proliferation of the
non-sensory epithelial regions at the stages when they are ﬁrst
developing, we labeled M-phase cells at E11.5 and S-phase cells at
E13.5 with antibodies directed against phospho-Histone H3 and
pulse-incorporated BrdU, respectively. Samples were co-stained
with antibodies directed against SOX2 to distinguish prosensory
(SOX2þ) from non-sensory (SOX2) domains (Fig. 7A–D). We
determined the average number of proliferation marker-positive
cells per unit area in each of the two epithelial domains, but no
signiﬁcant differences between genotypes were evident in either
domain at either stage (Fig. 7E and F). A limited number of E12.5
and E14.5 BrdU-labeled samples were examined and these also
showed no evidence of differences between genotypes (data not
shown). Similarly, labeling of dying cells at E13.5 with antibodies
directed against cleaved Caspase 3 failed to reveal differences
between genotypes in either the SOX2þ or SOX2 domain
(Fig. 7G and H; n¼3 each); however, the very small number of
dying cells, in both control and mutant epithelia, precluded
detailed quantitation. Thus, neither proliferation nor cell survival
in the non-sensory regions appear to require Fgf10.
Discussion
Fgf10 is expressed robustly in the developing inner ear epithelium
and ganglion, and has known roles in vestibular morphogenesis. To
determine its roles in cochlear development we studied global null
mutants and found that in addition to the previously described defects
of vestibular morphogenesis in homozygous null mutants (Ohuchi et
al., 2005; Pauley et al., 2003), the heterozygotes showed a fully
penetrant reduction or loss of the posterior semicircular canal,
indicating that this region of the otic labyrinth is particularly sensitive
to FGF10 dosage. We also found that while some Fgf10 null mutants
had defects of semicircular canal formation similar to those described
previously (Ohuchi et al., 2005; Pauley et al., 2003), others had a more
severe defect in which canal fusion plates failed to clear. Most
signiﬁcantly, and the focus of this report, we found that homozygous
null mutants had a previously undetected cochlear defect, namely loss
or reduction of two non-contiguous non-sensory domains, Reissner's
membrane and the outer sulcus, respectively (Fig. 8). This was
accompanied by a noticeable shortening of the cochlear duct.
These new cochlear data suggest an interesting parallel between
the function of Fgf10 in the vestibular compartment and its action in
the cochlea. Fgf10 is expressed in the developing semicircular canal
prosensory domain (giving rise to the cristae) while Fgfr2b is
expressed in the non-sensory canal epithelium. Loss of Fgf10 or
chemical blockage of FGF signaling results in the non-sensory canal
defects shown here and previously by others (Chang et al., 2004;
Ohuchi et al., 2005; Pauley et al., 2003). Similarly, Fgf10 is expressed
in a sensory-competent domain early in cochlear development,
eventually becoming restricted in mice to lateral Kolliker's organ,
adjacent to the organ of Corti (Ohyama et al., 2010; Pujades et al.,
2006; Sanchez-Guardado et al., 2013), and, as we have shown here,
is required for speciﬁcation of two non-sensory domains expressing
Fgfr2b. Thus, in contrast to the epithelial-mesenchymal signaling
paradigm apparent in other FGF10-dependent structures (Beenken
and Mohammadi, 2009; Itoh and Ornitz, 2011; Turner and Grose,
2010), non-sensory development in the inner ear may depend upon
intraepithelial paracrine signaling as posited by Pirvola et al. (2000).
When and how do the Fgf10 cochlear phenotypes arise?
Analysis of numerous cell type speciﬁc markers showed that the
two affected non-sensory tissues appear to initiate development at
different times when Fgf10 and Fgfr2b are expressed in adjacent
cochlear epithelial domains, with the medial Reissner's membrane
initiating ﬁrst at E12.5–13.5, and the lateral outer sulcus domain
initiating later at E15.5 (Fig. 8). The failure to generate these two
non-sensory tissues did not appear to be compensated for by
expansion of other tissues, and by E15.5, the mutant cochlear duct
area was signiﬁcantly less than that of controls. The lack of an
effect on proliferation or cell death at the two boundaries of the
Fgf10 and Fgfr2b expression domains suggests that both pheno-
types are likely to result from defects of localized progenitor cell
speciﬁcation rather than a failure of proliferation or cell survival.
Fgf10 and Reissner's membrane
The molecular mechanisms by which FGF10 induces Reissner's
membrane and outer sulcus development are not clear, but our data
suggest some possibilities that could be tested in future studies.
Reissner's membrane spans the region between Kolliker's organ and
the stria vascularis. It consists of an inner, epithelial layer facing the
endolymph of the scala media and an outer mesothelial layer facing
the perilymph of the scala vestibuli. Its function is to help maintain
the distinct ionic compositions of endolymph and perilymph (Kim
et al., 2014; Kim and Marcus, 2011) as well as to propagate traveling
waves that play a role in otoacoustic emissions (Reichenbach et al.,
2012). The genetic networks required for Reissner's membrane
development are unexplored. Ours is the ﬁrst report detailing the
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speciﬁc and complete loss Reissner's membrane via mutation of a
gene expressed locally within the cochlear epithelium. Given the
dramatic reduction of Fgf9 found in the presumptive Reissner's
membrane of Fgf10 null mutants at E12.5–E13.5, it is tempting to
speculate that Fgf9 functions downstream of Fgf10 in speciﬁcation of
Reissner's membrane. However, Fgf9 null mutants retain Reissner's
membrane, albeit with detachment of the mesothelial and epithe-
lial layers. In addition, Fgf9 mutants exhibit other dysmorphic
features of the scala vestibuli (enlargement and irregular trabecu-
lae) and they have a normally proportioned and elongated cochlea
(Pirvola et al., 2004). None of these features are recapitulated in
Fgf10 mutants. Thus, the down-regulation of Fgf9 in the Fgf10 null
cochleae may be more correlative than causal, and low-level
expression of Fgf9 at E12.5–13.5 in Fgf10 mutants may be sufﬁcient
to provide its normal function in signaling to the mesenchyme.
Aldh1a2, encoding a retinoic acid biosynthetic enzyme, is strongly
expressed in the mesenchymal/mesothelial domain of Reissner's
membrane at E18.5 and was absent in Fgf10 mutants, but we did
not observe any expression in or adjacent to the cochlear duct at
E12.5–E13.5, when Reissner's membrane is induced. Thus it is
unlikely to play a role downstream of Fgf10 in its speciﬁcation.
Nevertheless, the later mesechymal/mesothelial expression of
Aldh1a2 remains suggestive of a role in Reissner's membrane devel-
opment, possibly in conjunction with epithelial Fgf9. Addressing this
issue will require analysis of appropriate conditional mutants.
Lmx1a, which encodes a LIM homeodomain-containing tran-
scription factor and is expressed in the prospective and late
embryonic epithelial Reissner's membrane of controls, but was
absent from Fgf10 null mutants, may be a more likely candidate as
a downstream effector of FGF10 signaling in Reissner's membrane
speciﬁcation. Lmx1a likely null mutants (dreher, mtl, bsd) have
dysmorphic cochleae in which the basal sensory domain is merged
with and resembles a neighboring vestibular sensory domain (Koo
et al., 2009; Nichols et al., 2008; Steffes et al., 2012), suggesting
improper sensory boundary formation. This phenotype is not seen
in Fgf10 null mutants. However, Reissner's membrane appears
abnormal in Lmx1a mutants, with a possible reduction in the
cross-sectional area of the cochlear duct (Nichols et al., 2008), and
further examination and comparison with Fgf10 null mutants is
warranted. In addition, as in Fgf10 null mutants, the Lmx1a mutant
Fig. 6. The effects of FGF10 absence on Reissner's membrane development precede those on outer sulcus development. In situ hybridization analyses of basal cochlear duct
cross sections at E13.5 (A–J) and E12.5 (K–T). Genotypes are indicated to the left of each row and probes are indicated to the upper right of the top panels. Dashed and solid
black lines indicate expression that is altered or unchanged, respectively, in mutants. The cochlear duct is outlined with a dashed gray line. U. Graphical comparison of the
cochlear duct area of the basal scala media at the developmental ages shown (n¼3 controls and 3 mutants). Abbreviations: Ko, Kolliker's organ; Rm, presumptive Reissner's
membrane; os, outer sulcus; ps, prosensory region; sg, spiral ganglion; sv, stria vascularis. Scale bar in A applies to all panels.
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cochleae are shortened (Koo et al., 2009; Nichols et al., 2008;
Steffes et al., 2012). As Fgf10 transcripts are not affected in the
Lmx1a cochlea (Nichols et al., 2008), but the Reissner's membrane
and outer sulcus domains of Lmx1a transcripts are absent from
Fgf10 null mutants (this study), it is likely that Fgf10 is upstream of
Lmx1a. Whether Lmx1a actually mediates FGF10 functions in the
cochlear duct could only be tested by replacing its function in the
Fgf10 null mutant.
Fgf10 and the outer sulcus
Similar to the role of Reissner's membrane, the outer sulcus
provides a crucial component of the non-sensory epithelial compart-
ment of the cochlear duct. Cells in this domain actively reabsorb
cations from the endolymph, providing the optimum homeostatic
environment for mechanoelectrical transduction to occur in hair cells
(Jagger and Forge, 2013; Kim and Marcus, 2011). As with Reissner's
membrane, we do not yet have a clear grasp on the regulatory
pathways by which Fgf10 orchestrates outer sulcus development, but
it is reasonable to suggest that Fgf10 may do so by regulating
expression of Bmp4. Conditional mutagenesis of Alk3 and Alk6,
encoding type I BMP receptors, revealed that BMP signaling, like
Fgf10 signaling, is required for outer sulcus speciﬁcation and normal
cochlear length. The Alk mutants exhibit a lateral expansion of the
cochlear Fgf10 expression domain in Kolliker's organ at E13.5.
Furthermore, exposure of cochlear organ cultures to BMP4 ligand
induces markers of the outer sulcus and suppresses Fgf10 and other
markers of Kolliker's organ, suggesting that BMP signaling negatively
regulates FGF signaling in the cochlear duct. (Ohyama et al., 2010).
Our data suggest that FGF10 may be a positive regulator of Bmp4
expression, but since there is residual Bmp4 expression and residual
outer sulcus tissue in Fgf10 mutants and other BMP ligands may also
be present in either the epithelium or mesenchyme, it is not
surprising that we did not observe an expansion of the Fgf10Δ2
expression domain in mutants. Further studies will be required to
dissect the regulatory relationships between FGF and BMP signaling
in cochlear duct patterning and morphogenesis. In addition, it will be
interesting to learn whether removing the remaining FGFR2b ligand
(FGF3) leads to complete deletion of the outer sulcus.
Fgf10 and cochlear length
Despite the obvious, but relatively mild, shortening of the
cochlear duct noted in gross observations of Fgf10 null mutants,
we did not detect proliferative differences that could account for
this phenotype. Additional studies may be necessary to determine
if the shortening is in fact caused by small effects on proliferation
or instead by an alternative mechanism, such as a slowing of
convergent extension (McKenzie et al., 2004; Yamamoto et al.,
2009). Indeed, the cells in the residual Bmp4-positive outer sulcus
region of the mutants appear taller than those of control cochleae.
As reducing the dosage of Fgf3, which encodes a ligand with the
same receptor activating proﬁle as FGF10 (Zhang et al., 2006),
leads to further shortening of the Fgf10 null cochlea (data not
shown, manuscript in preparation), and Fgfr2b null mutants never
develop a cochlea (Pirvola et al., 2000), we suspect that FGF10
Fig. 7. Neither cell proliferation nor cell survival is altered in Fgf10 null cochlear ducts. Double labeling of control (A) and Fgf10 null (B) E11.5 cochlear duct cross sections with
antibodies directed against phospho-Histone H3 (red) and SOX2 (green). Nuclei are counterstained with DAPI (blue). Double labeling of control (C) and Fgf10 null (D) E13.5 cochlear
duct cross sections with antibodies directed against BrdU (red) and SOX2 (green). Dotted lines delineate the regions considered non-sensory (SOX2-). The remaining SOX2þ areas
were considered prosensory. Graphical comparisons of the mean number of proliferating cells per pixel2 in SOX2þ (E) and SOX2- (F) regions of control (white bars) and Fgf10 null
mutants (black bars). Error bars indicate standard deviation (SD). Double labeling of control (G) and Fgf10 null (H) E13.5 cochlear duct cross sections with antibodies directed against
cleaved Caspase 3 (cCasp3; red) and SOX2 (green). Nuclei are counterstained with DAPI (blue). Abbreviation: g, ganglion. Scale bar in panel A applies to all images.
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together with FGF3-stimulated proliferation will prove to be one of
the factors regulating cochlear length.
Implications for human hearing loss
Heterozygous mutations in FGF10 leading to reduced signaling
activity are a cause of the very rare autosomal dominant LADD
(lacrimo-auriculo-dento-digital) syndrome and its allelic variant,
ASLG (aplasia of lacrimal and salivary glands) syndrome. LADD
syndrome is also caused by heterozygous mutations in FGFR2 and
FGFR3 that reduce signaling activity (Milunsky et al., 2006;
Rohmann et al., 2006; Shams et al., 2007). Neither LADD nor ASLG
subjects, nor mice that are heterozygous for Fgf10, Fgfr2 or Fgfr3
loss-of-function mutations have ever been reported with vestibu-
lar symptoms. In light of our ﬁndings that Fgf10 /þ mice have
posterior semicircular canal defects, it would be interesting to
image the inner ears of LADD subjects with known FGF10 muta-
tions to determine the status of the posterior semicircular canal.
Interestingly, there is a case report of a LADD syndrome subject
with unilateral dysplastic posterior and lateral semicircular canals
(Moses, 2013), and another with bilateral dysplasia of the semi-
circular canals (Azar et al., 2000), but no information about the
responsible mutations is available. Given that only one semicir-
cular canal is affected in mice, it is likely that the remainder of the
vestibular system compensates, though it is possible that an
abnormal vestibular phenotype might be revealed with speciﬁc
testing.
55% of LADD syndrome subjects are reported with hearing loss
(Milunsky et al., 2006), but the type (conductive, sensorineural or
mixed) is not always speciﬁed and the mutation status is rarely
known. Nevertheless, imaging of some of these individuals has
revealed cochlear hypoplasia (Lemmerling et al., 1999; Meuschel-
Wehner et al., 2002; Moses, 2013). We did not detect any
morphologic or molecular aberrations in the cochlear ducts of
Fgf10 heterozygotes and their hearing is normal (Mansour et al.,
2013), but homozygotes had cochlear defects that would be
expected to cause hearing loss if the other major consequences
of Fgf10 homozygosity, such as the failure of lung development,
could be bypassed. In particular, the failure of normal Reissner's
membrane and outer sulcus development, both of which are
important in maintaining the endolymph homeostasis necessary
for hearing, suggests that these tissues could be compromised to
some extent even in LADD syndrome subjects without reported
cochlear malformations and might contribute to the hearing loss
reported in some individuals. Our inner ear ﬁndings in mice
suggest that LADD and ASLG syndrome subjects should receive
hearing and vestibular function evaluations and counseling as part
of their clinical care.
In summary, our ﬁndings on the development of Fgf10 null
inner ears provide new insight into the speciﬁcation of cochlear
non-sensory domains and suggest a basis for the hearing loss
reported for some LADD syndrome subjects.
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